Clinical Trial Update: Breath-hold Cardiac Hybrid SPECT/CCTA [NA]

View source ↗

Summary

A completed clinical trial evaluating breath-hold cardiac hybrid SPECT/CCTA for coronary artery disease; no efficacy results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: University of Zurich | Conditions: Coronary Artery Disease | NA | Status: COMPLETED